Market cap
$2.501 B
$11.47 +1.50%
Close of 7 Aug 2026
Revenue
$870.4M
#1605 by revenue
Earnings
-$7.90M
Loss-making
Shares outstanding
218,056,016
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Biotechnology: In Vitro & In Vivo Diagnostic Substances — ranked by market cap
All 19 →Where these numbers come from
Share counts and financials for Neogen are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.